Agnieszka Boesen

Array ( [id] => 13300737 [patent_doc_number] => 20180201905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => OPTIMIZED HCV FULL-LENGTH INFECTIOUS CELL CULTURE SYSTEMS AND APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 15/522745 [patent_app_country] => US [patent_app_date] => 2015-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17545 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15191351 [patent_doc_number] => 10493146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-03 [patent_title] => Live attenuated viral vaccine created by self-attenuation with species-specific artificial MicroRNA [patent_app_type] => utility [patent_app_number] => 15/518781 [patent_app_country] => US [patent_app_date] => 2015-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 21 [patent_no_of_words] => 7104 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15518781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10721080 [patent_doc_number] => 20160067228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-10 [patent_title] => 'METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 14/846949 [patent_app_country] => US [patent_app_date] => 2015-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 48873 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14846949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12023665 [patent_doc_number] => 20170313764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'HEPATITIS C VIRUS SPECIFIC ANTIBODY' [patent_app_type] => utility [patent_app_number] => 15/508570 [patent_app_country] => US [patent_app_date] => 2015-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 37944 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11969910 [patent_doc_number] => 20170274064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-28 [patent_title] => 'MODIFIED BAT INFLUENZA VIRUSES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 15/508670 [patent_app_country] => US [patent_app_date] => 2015-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 17943 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14794045 [patent_doc_number] => 10400015 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-03 [patent_title] => Recombinant HIV-1 envelope proteins and their use [patent_app_type] => utility [patent_app_number] => 15/508885 [patent_app_country] => US [patent_app_date] => 2015-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 97 [patent_figures_cnt] => 150 [patent_no_of_words] => 98281 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14883557 [patent_doc_number] => 10421805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-24 [patent_title] => Anti-hepatitis C antibodies and antigen binding fragments thereof [patent_app_type] => utility [patent_app_number] => 15/507676 [patent_app_country] => US [patent_app_date] => 2015-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 21058 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11457140 [patent_doc_number] => 20170051046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-23 [patent_title] => 'H1N1 FLU VIRUS NEUTRALIZING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/831167 [patent_app_country] => US [patent_app_date] => 2015-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6602 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14831167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17541254 [patent_doc_number] => 11306367 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-04-19 [patent_title] => Methods for rapid detection and identification of viral nucleic acids [patent_app_type] => utility [patent_app_number] => 14/821865 [patent_app_country] => US [patent_app_date] => 2015-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 43 [patent_no_of_words] => 27389 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14821865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11850320 [patent_doc_number] => 20170224812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'LIQUID IMMUNITY INDUCTION-PROMOTING COMPOSITION AND VACCINE PHARMACEUTICAL COMPOSITION THAT INCLUDE THROMBOSIS TREATMENT DRUG' [patent_app_type] => utility [patent_app_number] => 15/501339 [patent_app_country] => US [patent_app_date] => 2015-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14246 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10699435 [patent_doc_number] => 20160045583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'Tumor Vaccine' [patent_app_type] => utility [patent_app_number] => 14/812416 [patent_app_country] => US [patent_app_date] => 2015-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18790 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14812416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10445968 [patent_doc_number] => 20150330982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-19 [patent_title] => 'PRETREATMENT METHOD OF SAMPLE FOR DETECTING HBS ANTIGEN AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/809432 [patent_app_country] => US [patent_app_date] => 2015-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11095 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14809432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15381877 [patent_doc_number] => 10532097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-14 [patent_title] => Multi-drug delivery system and use thereof [patent_app_type] => utility [patent_app_number] => 15/325346 [patent_app_country] => US [patent_app_date] => 2015-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 9760 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16771095 [patent_doc_number] => 10982189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-20 [patent_title] => Methods of improving vector transduction efficiency into T lymphocytes [patent_app_type] => utility [patent_app_number] => 15/325376 [patent_app_country] => US [patent_app_date] => 2015-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9196 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10443296 [patent_doc_number] => 20150328308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-19 [patent_title] => 'Means for Eliciting an Immune Response and a Method Transfer' [patent_app_type] => utility [patent_app_number] => 14/739570 [patent_app_country] => US [patent_app_date] => 2015-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9077 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14739570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11942153 [patent_doc_number] => 20170246293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'SYNTHETIC LONG PEPTIDES (SLP) FOR THERAPEUTIC VACCINATION AGAINST HEPATITIS B VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 15/315526 [patent_app_country] => US [patent_app_date] => 2015-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 82588 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11507334 [patent_doc_number] => 09598481 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-21 [patent_title] => 'Anti-hemagglutinin antibodies and methods of use' [patent_app_type] => utility [patent_app_number] => 14/725508 [patent_app_country] => US [patent_app_date] => 2015-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 73 [patent_no_of_words] => 43992 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14725508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14637145 [patent_doc_number] => 10363301 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-30 [patent_title] => Stabilized influenza hemagglutinin stem region trimers and uses thereof [patent_app_type] => utility [patent_app_number] => 15/313265 [patent_app_country] => US [patent_app_date] => 2015-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 44 [patent_no_of_words] => 44348 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11756025 [patent_doc_number] => 20170202892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'CONDITIONALLY REPLICATING ADENOVIRUS TO EXPRESS REIC GENE' [patent_app_type] => utility [patent_app_number] => 15/313674 [patent_app_country] => US [patent_app_date] => 2015-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8715 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10354954 [patent_doc_number] => 20150239959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 14/707014 [patent_app_country] => US [patent_app_date] => 2015-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 23124 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707014 [rel_patent_id] =>[rel_patent_doc_number] =>)